Csar, T.B., Barbalho, S.M., Chermut, T.R., et al
Este medicamento no deve ser utilizado por mulheres amamentando, grvidas e adolescentes com idade inferior a 18 anos sem orientao mdica
Emerging evidence points to broad therapeutic potential across metabolic regulation, cardiovascular and hepatic function, neurodegenerative processes, and behavioural health
Tackling a major deficiency of diversity in Alzheimers disease therapeutic trials: an CTAD Task Force report
In addition, we examined the protein level of Iba-1 in the TNC using western blotting and found that liraglutide markedly reduced NTG-induced upregulation of Iba-1 (CM + Lira 0.76 0.12 vs